Tip 2 Diyabetli Hastalarda Tedaviye Uyumun Komplikasyon Riski Algısı ve Metabolik Kontrol Üzerindeki Etkisi

Öz

Amaç: Bu çalışma tip 2 diyabetli hastalarda tedaviye uyumun komplikasyonlara ilişkin risk algısı ve metabolik kontrole etkisinin belirlenmesi amacıyla yapılmıştır. Gereç ve Yöntemler: Tanımlayıcı tipteki bu araştırmanın örneklemini Fırat Üniversitesi Hastanesi’nde Ekim 2023-Mart 2024 tarihleri arasında Endokrin Servisinde yatarak tedavi gören, çalışmaya katılmaya gönüllü, 18 yaş ve üstü 206 tip 2 diyabetli hasta oluşturmuştur. Çalışma verilerinin toplanmasında hastaların tanıtıcı özelliklerini içeren "Hasta Tanıtım Formu", "Tip 2 Diabetes Mellitus Tedavisine Hasta Uyum Ölçeği", "Komplikasyonlara İlişkin Risk Algısı Ölçeği" ve "Metabolik Değerler Kontrol Formu" kullanılmıştır. Değerlendirmede tanımlayıcı istatistikler ve Korelasyon istatistik analiz yöntemleri kullanılmıştır. Bulgular: Araştırmada hastaların tedaviye uyum düzeyinin orta (79,86±11,46), komplikasyonlara yönelik risk algısı düzeyinin yüksek (2,94±0.25), komplikasyonlara yönelik algılanan risk düzeyinin orta (2.09±0,42) düzeyde olduğu belirlenmiştir. Tip 2 Diabetes Mellitus Tedavisine Hasta Uyum Ölçeği ile bileşik risk algısı arasında negatif yönde anlamlı ilişki olduğu görülmüştür (p< 0.05). Tedaviye uyum ile bazı metabolik değişkenler arasında pozitif yönde anlamlı ilişki olduğu görülmüştür (p< 0.05). Tedaviye uyum düzeyinin risk bilgisi, kişisel hastalık riski algısı ve açlık kan şekeri düzeyi ile anlamlı şekilde ilişkili olduğu bulunmuştur (F = 3.765, p = 0.000). Sonuç: Bu çalışmada, tip 2 diyabetli bireylerde tedaviye uyum düzeyinin; risk algısı bileşenlerinden risk bilgisi ve kişisel hastalık riski ile birlikte açlık kan şekeri düzeyini anlamlı şekilde yordadığı bulunmuştur. Buna karşın diğer risk algısı boyutları ve metabolik değişkenlerin çoğunun tedaviye uyum üzerinde anlamlı bir etkisi saptanmamıştır. Bu bulgular, bireylerin hastalıkla ilgili bilgi ve risk algılarının, tedaviye uyum davranışlarını etkileyen önemli faktörler olduğunu göstermektedir

Anahtar Kelimeler

• Metabolik kontrol
• Risk algısı
• Tedaviye uyum
• Tip 2 diyabet

The Effect of Treatment Adherence on Risk Perception of Complications and Metabolic Control in Patients with Type 2 Diabetes

Öz

Aim: This study was conducted to determine the effect of treatment compliance on risk perception of complications and metabolic control in patients with type 2 diabetes. Material and Methods: The sample of this descriptive study consisted of 206 type 2 diabetic patients aged 18 years and older who were hospitalized October 2023 and March 2024 and who volunteered to participate in the study. In the collection of the study data, the ''Patient Introduction Form'', which includes the descriptive characteristics of the patients, ''Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment'', ''Risk Perception Scale for Complications'' and ''Metabolic Values Control Form'' were used. Descriptive statistics and correlation statistical analysis methods were used in the evaluation. Results: In the study, it was determined that the level of compliance to treatment was moderate (79.86±11.46), the level of risk perception towards complications was high (2.94±0.25), and the level of perceived risk towards complications was moderate (2.09±0.42). There was a significant negative correlation between the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment and composite risk perception (p <0.05). There was a significant positive correlation between compliance to treatment and some metabolic variables (p< 0.05). Treatment compliance level was found to be significantly associated with risk knowledge, personal perception of disease risk and fasting blood glucose level (F = 3.765, p <0.001). Conclusion: In this study, it was found that the level of compliance to treatment significantly predicted fasting blood glucose level in individuals with type 2 diabetes along with risk knowledge and personal disease risk among risk perception components. However, other risk perception dimensions and most of the metabolic variables had no significant effect on treatment compliance. These findings suggest that individuals' disease knowledge and risk perceptions are important factors affecting their treatment compliance behaviors

Anahtar Kelimeler

• Metabolic control
• Risk perception
• Treatment compliance
• Type 2 diabetes

Kaynakça

1. 1. Wakui N, Ozawa M, Yanagiya T, Endo S, Togawa C, Matsuoka R, et al. Factors Associated With Medication Compliance in Elderly Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study. Front Public Heal. 2022;9(January):1–9.
2. 2. Idris BNA, Hapipah, Ariyanti M, Arifin Z, Supriyadi, Mardiyah Z. Effect of Spiritual Care Towards Diet Compliance in Diabetes Mellitus Type 2 Patients. 2020;30(Ichd):1–7.
3. 3. IDF. İnternational Diabetes Federation, 2021 [Internet]. 2021. Available from: https://diabetesatlas.org/
4. 4. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–80.
5. 5. Shahabi N, Kolivand M, Salari N, Abbasi P. The effect of telenursing training based on family-centered empowerment pattern on compliance with diet regimen in patients with diabetes mellitus type 2: a randomized clinical trial. BMC Endocr Disord [Internet]. 2022;22(1):1–8. Available from: https://doi. org/10.1186/s12902-022-00953-4
6. 6. Aytemur M, İnkaya B. Investigation of Diabetes Complication Risk Perception and Diabetes Self-Management Skills in Individuals with Diabetes. Turkish J Diabetes Obes. 2022;6(2):121– 30.
7. 7. Javanmardifard S, Heidari S, Sanjari M, Yazdanmehr M, Shirazi F. The relationship between spiritual well-being and hope, and compliance to treatment regimen in patients with diabetes. J Diabetes Metab Disord. 2020;19(2):941–50.
8. 8. Koenigsberg MR, Corliss J. Diabetes Self-Management: Facilitating Lifestyle Change. Am Fam Physician [Internet]. 2017;96(6):362–70. Available from: www.aafp.org/ afp.%0Ahttp://eds.a.ebscohost.com.ezproxy.endeavour.edu. au/eds/pdfviewer/pdfviewer?vid=3&sid=85482eef-0a02-428c -8418-d575ba85b524%40sessionmgr4010

9. 9. Monju IH, Ahmed T, Abrar M, Habib MA, Faiza F, Hawlader MDH, et al. Prevalence and factors associated with medication compliance among diabetes patients in rural sub-district health facilities in Bangladesh. Discov public Heal [Internet]. 2025;22(1). Available from: https://doi.org/10.1186/s12982- 025-00504-x
10. 10. Arı N, Özdelikara A. The Effect of Family Support on Acceptance and Treatment Adaptation in Type 2 Diabetes Patients Applied to Internal Medicine Clinics: Ordu Province Sample. Turkish J Diabetes Obes. 2022;6(1):39–48.
11. 11. Sağlam FS, Bektas H. Risk perceptions of patients with type 2 diabetes mellitus regarding insulin therapy and diabetes complications: A cross-sectional study. J Clin Nurs. 2023;32(15– 16):5010–27. doi: 10.1111/jocn.16720.
12. 12. Rashidi M, Kiskaç N, Gelişim Üniversitesi İ, Bilimleri Fakültesi S, Bölümü H, yazar S. Diyabetli Bireylerde Diyabet Komplikasyon Risk Algısının ve Diyabet Öz Yönetim Algısı Arasındaki İlişkinin İncelenmesi. Mas Japs [Internet]. 2024;9(1):50–7. Available from: http://dx.doi.org/10.5281/zenodo.10614786
13. 13. Ahmed NJ, Alrawili AS, Alkhawaja FZ, Alqahtani HF, Alanazi RH. Knowledge and Perception about Diabetes and its Risk Factors. J Pharm Res Int. 2021;33:423–7. DOI: 10.9734/ jpri/2021/v33i43A32507
14. 14. Demirtaş A, Albayrak A. Development of an assessment scale for treatment compliance in type 2 Diabetes Mellitus in Turkish population: Psychometric evaluation. Int J Nurs Sci. 2017;4:244–51. doi: 10.1016/j.ijnss.2017.06.002. eCollection 2017 Jul 10.
15. 15. Walker EA, Caban A, Schechter CB, Basch CE, Blanco E, DeWitt T, et al. Measuring comparative risk perceptions in an urban minority population: The risk perception survey for diabetes. Diabetes Educ. 2007;33(1):103–10. doi: 10.1177/0145721706298198.
16. 16. Taskin Yilmaz F, Karakoc Kumsar A, Celik S. The Validity and Reliability Study of the Turkish Risk Version of the Perception Survey-Diabetes Mellitus Scale. Int J Caring Sci. 2018;11(3):1597–608.
17. 17. Erden Melikoğlu S, Köktürk Dalcali B, Güngörmüş E, Kaya H. Spiritual Well-Being and Treatment Compliance in Patients with Type 2 Diabetes in Turkey. J Relig Health [Internet]. 2025;(0123456789). Available from: https://doi.org/10.1007/ s10943-025-02271-0
18. 18. Eşki Ş, Yalçınöz Baysal H. An investigation of the diabetes health literacy level and compliance to the treatment in patients with diabetes in Turkey. Anatol Curr Med J. 2022;4(1):1– 7.
19. 19. Yildirim D, Çiriş Yildiz C, Ergin E, Özbay İ. Hypoglycaemia fear, treatment compliance, and the quality of life in patients with type 2 diabetes and its determinants. Int J Nurs Pract. 2024;30(2):1–9. https://doi.org/10.1111/ijn.13248
20. 20. Fayed A, AlRadini F, Alzuhairi RM, Aljuhani AE, Alrashid HR, Alwazae MM, et al. Relation between diabetes related distress and glycemic control: The mediating effect of compliance to treatment. Prim Care Diabetes [Internet]. 2022;16(2):293–300. Available from: https://doi.org/10.1016/j.pcd.2021.12.004
21. 21. Xiong C, Wang Y, Xie X, Huang Y, Liu M, Zou X. Mediating Effect of Coping Style Between Risk Perception of Complications and Self-Management in Patients with Type 2 Diabetes Mellitus. Diabetes, Metab Syndr Obes . 2024;17(November): 4367–76. doi: 10.2147/DMSO.S490286.
22. 22. Kumsar A, Yilmaz F, Celik S, Bagdemir E. The perception of risk related to complications and its relation with metabolic parameters in diabetic individuals. Ann Med Res. 2021;28(1):55.
23. 23. Shreck E, Gonzalez JS, Cohen HW, Walker EA. Risk perception and self-management in urban, diverse adults with type 2 diabetes: The improving diabetes outcomes study. Int J Behav Med. 2014;21(1):88–98. doi: 10.1007/s12529-013-9291-4.
24. 24. Alharbi S, Alhofaian A, Alaamri MM. Illness Perception and Medication Compliance among Adult Patients with Type 2 Diabetes Mellitus: A Scoping Review. Clin Pract. 2023;13(1):71– 83. doi: 10.3390/clinpract13010007
25. 25. Pourhabibi N, Mohebbi B, Sadeghi R, Shakibazadeh E, Sanjari M, Tol A, et al. Factors associated with treatment compliance to treatment among in patients with type 2 diabetes in Iran: A cross-sectional study. Front Public Heal. 2022;10. doi: 10.3389/ fpubh.2022.976888
26. 26. Gomes-Villas Boas LC, Foss MC, Freitas MCF de, Pace AE. Relationship among social support, treatment compliance and metabolic control of diabetes mellitus patients. Rev Lat Am Enfermagem. 2012;20(1):52–8. DOI: 10.1590/s0104- 11692012000100008
27. 27. Wibowo, Z.K., Wibisono, S., Khairina. The relationship between diabetes distress and HbA1C level in type 2 diabetes mellitus therapy patients: a systematic review. Bali Medical Journal. 2022;11(1): 476-484. DOI: 10.15562/bmj.v11i1.2986
28. 28. Han F, Shi X, Pan J, et al. Elevated serum HbA1c level, rather than previous history of diabetes, predicts the disease severity and clinical outcomes of acute pancreatitis. BMJ Open Diab Res Care 2023;11:e003070. doi:10.1136/bmjdrc-2022-003070
29. 29. Quigley M, Earnest A, Szwarcbard N, Wischer N, Andrikopoulos S, Green S, et al. (2022) Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors. PLoS ONE 17(2): e0263511.https:// doi.org/10.1371/journal.pone.0263511
30. 30. Lee SF, Li CP. Personality as a predictor of HbA1c level in patients with type 2 diabetes mellitus. Medicine (2021) 100:27. DOI: 10.1097/MD.0000000000026590
31. 31. Simon-Tuval T, Shmueli A, Harman-Boehm I. Compliance of patients with type 2 diabetes mellitus to medications: the role of risk preferences. Curr Med Res Opin [Internet]. 2018;34(2):345–51. Available from: https://doi.org/10.1080/03 007995.2017.1397506
32. 32. Neto JCGL, Da Silva AP, De Araújo MFM, Damasceno MMC, Landim MBP, De Freitas RWJF. Metabolic control and medication compliance in people with diabetes mellitus. ACTA Paul Enferm. 2017;30(2):152–8. DOI: 10.1590/1982- 0194201700024
33. 33. Turen S, Yilmaz RA, Gundogdu S. The Relationship with Acceptance of Illness and Medication Compliance in Type 2 Diabetes Mellitus Patients. Int J Caring Sci [Internet]. 2021;14(3):1824. Available from: www.internationaljournalofcaringsciences. org